Effect of 1,19-Bis(ethylamino)-5,10,15-triazanonadecane on Human Tumor Xenografts

Cancer Research

Volumn 54, Issue 17, 1994, Pages 4698-4702

  Dolan, M Eileen ^a   Fleig, Matthew J ^a   Feuerstein, Burt G ^b,c   Basu, Hirak S ^b   Luk, Gordon D ^d   Casero, Robert A ^e   Marton, Laurence J ^f  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b Department of Laboratory Medicine ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,19 BIS(ETHYLAMINO) 5,10,15 TRIAZANONADECANE; BE 4444; CARMUSTINE; POLYAMINE DERIVATIVE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; COLON CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; FEMALE; GLIOBLASTOMA; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG ADENOCARCINOMA; MITOSIS INDEX; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR VOLUME; TUMOR XENOGRAFT; WEIGHT REDUCTION;

ANIMAL; BODY WEIGHT; BRAIN NEOPLASMS; CARMUSTINE; CELL DIVISION; COLONIC NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; GLIOBLASTOMA; HUMAN; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; SPERMINE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0028169362     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Pegg, A. E., Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 48: 759-774, 1988.
2. McCann, P. P., Pegg, A. E., and Sjoerdsma, A. Inhibition of Polyamine Metabolism. Biological Significance and Basis for New Therapies. Orlando, FL: Academic Press, 1987.
3. Pendyala, L. Creaven, P. J., and Porter, C. W., Polyamine levels in red blood cells of subjects receiving α-difluoromethylornithine in a phase I chemoprevention study. In: R.H. Dowling, U. R., Folsch, and C, Loser (eds.), Falk Symposium on Poly-amines in the Gastrointestinal Tract, pp. 193-202. Dordrecht, the Netherlands: Kluwer Academic Publishers, 1992.
4. Levin, V. A., Prados, M. D., Yung, W. K., Gleason, M. J., Ictech, S. and Malec, M. Treatment of recurrent gliomas with eflornithine. J. Natl. Cancer Inst. 84: 1432-1437, 1992.
5. Prados, M. Rodriguez, L. Chamberlain, M. Silver, P. and Levin, V. Treatment of recurrent gliomas with l, 3-bis(2-chloroethyl)-l-nitrosourea and α-difluoromethylornithine. Neurosurgery (Baltimore), 24: 806-809, 1989.
6. Schechter, P. J., Barlow, J.L.R. and Sjoerdsma, A. Clinical aspects of inhibition of ornithine decarboxylase with emphasis on therapeutic trials of eflornithine (DFMO) in cancer and protozoan diseases. In: P.P. McCann, A. E., Pegg, and A. Sjoerdsma (eds.), Inhibition of Polyamine Metabolism. Biological Significance and Basis for New Therapies, pp. 345-364. Orlando, FL: Academic Press, 1987.
7. Porter, C. W., McManis, J. Casero, R. A., and Bergeron, R. J., Relative abilities of bis(ethyl)derivatives of putrescine, spermidine and spermine to regulate polyamine biosynthesis and inhibit cell growth. Cancer Res. 47: 2821-2825, 1987.
8. Bergeron, R. J., Neims, A. H., McManis, J. S., Hawthorne, T. R., Vinson, J. R., Bortell, R. and Ingeno, M. J., Synthetic polyamine analogues as antineoplastics. J. Med. Chem. 31: 1183-1190, 1988.
9. Porter, C. W., and Bergeron, R. J., Enzyme regulation as an approach to interference with polyamine biosynthesis-an alternative to enzyme inhibition. In: G. Weber (ed.), Advances in Enzyme Regulation, Vol. 27, pp. 57-79. New York: Pergamon Press, 1988.
10. Edwards, M. L., Prakash, N. J., Stemerick, D. M., Sunkara, S. P., Bitonti, A. J., Davis, G. F., Dumont, J. A., and Bey, P. Polyamine analogues with antitumor activity. J. Med. Chem. 33: 1369-1375, 1990.
11. Feuerstein, B. G., Williams, L. D., Basu, H. S., and Marton, L. J., Implications and concepts of polyamine-nucleic acid interactions. J. Cell. Biochem. 46: 37-47, 1991.
12. Porter, C. W., Bernacki, R. Miller, J. and Bergeron, R. J., Antitumor activity of N1, N11,-bis(ethyl)norspermine against human melanoma xenografts and possible biochemical correlates of drug action. Cancer Res. 53: 581-586, 1993.
13. Basu, H. S., Pellarin, M. Feuerstein, B. G., Deen, D. F., Bergeron, R. J., and Marton, L. J., Effect of N1, Nl4-bis(ethyl)homospermine on the growth of U-87 MG and SF-126 human brain tumor cells. Cancer Res. 50: 3137-3140, 1990.
14. Chang, B. K., Bergeron, R. J., Porter, C. W., and Liang, Y. Antitumor effects of N-alkylated polyamine analogues in human pancreatic adenocarcinoma models. Cancer Chemother. Pharmacol. 30: 179-182, 1992.
15. Bernacki, R. J., Bergeron, R. J., and Porter, C. W., Antitumor activity of N, N1-bis(ethyl)spermine homologues against human MALME-3 melanoma xenografts. Cancer Res. 52: 2424-2430, 1992.
16. Porter, C. W., Berger, F. G., Pegg, A. E., Ganis, B. and Bergeron, R. J., Regulation of ornithine decarboxylase activity by spermidine and the spermidine analog, N1, N8-bis(ethyl)spermidine (BES). Biochem. J. 242: 433-440, 1987.
17. Casero, R. A., Jr. Mank, A. R., Xiao, L. Smith, J. Bergeron, R. J., and Celano, P. Induction of spermidine/spermine N1-acetyltransferase (SSAT) steady-state messenger RNA and activity correlates with sensitivity to N1, N12-bis(ethyI)spermine in human cell lines representing the major forms of lung cancer. Cancer Res. 52: 5359-5363, 1992.
18. Basu, H. S., Shafer, R. H., and Marton, L. J., A stopped-flow H-D exchange kinetic study of spermine-polynucleotide interaction. Nucleic Acids Res. 75: 5873-5886, 1987.
19. Marquet, R. and Houssier, C. Different binding modes of spermine to A-T and G-C base pairs modulate the bending and stiffening of the DNA double helix. J. Biomol. Struct. Dyn. 6: 235-246, 1988.
20. Gosule, L. C., and Schellman, J. A., Compact form of DNA induced by spermidine. Nature (Lond.), 259: 333-335, 1976.
21. Sen, D. and Crothers, D. M., Condensation of chromatin. Role of multivalent cations. Biochemistry, 25: 1495-1503, 1986.
22. Basu, H. S., and Marton, L. J., The interaction of spermine and pentamines with DNA. Biochem J. 244: 243-246, 1987.
23. Selvin, P. R., Scalettar, B. A., Langmore, J. P., Axelrod, M. D., Klein, M. P., and Hearst, J. E., A polarized photobleaching study of chromatin reorientation in intact nuclei. J. Mol. Biol. 214: 911-922, 1990.
24. Basu, H. S., Sturkenboom, M.C.J.M. Delcros, J. G., Csokan, P. P., Szollosi, J. Feuerstein, B. G., and Marton, L. J., Effect of polyamine depletion on chromatin structure in U-87 MG human brain tumor cells. Biochem. J. 283: 723-727, 1992.
25. Basu, H. S., Wright, W. D., Deen, D. F., Roti-Roti, J. and Marton, L. J., Treatment with polyamine analog alters DNA-matrix association in HeLa cell nuclei: a nucleoid halo assay. Biochemistry, 32: 4073-4076, 1993.
26. Basu, H. S., Schweitert, H.C.A. Feuerstein, B. G., and Marton, L. J., Effect of variation in the structure of spermine on the association with DNA and the induction of DNA conformational changes. Biochem. J. 269: 329-334, 1990.
27. Basu, H. S., Feuerstein, B. G., Deen, D. F., Lubich, W. P., Bergeron, R. J., Samejima, K. and Marton, L. J., Correlation between the effects of polyamine analogs on DNA conformation and cell growth. Cancer Res. 49: 5591-5597, 1989.
28. Basu, H. S., Pellarin, M. Feuerstein, B. G., Shirahata, A. Samejima, K. Deen, D. F., and Marton, L. J., Interaction of a polyamine analogue, l, 19-bis(ethylamino)-5, 10, 15-triazanonadecane (BE-4-4-4-4), with DNA and effect on growth, survival, and polyamine levels in seven human brain tumor cell lines. Cancer Res. 53: 3948-3955, 1993.
29. Marton, L. J., Levin, V. A., Hervatin, S. J., Koch-Weser, J. McCann, P. P., and Sjoerdsma, A. Potentiation of the antitumor therapeutic effects of l, 3-bis(2-chloro-ethyl)-l-nitrosourea by a-difluoromethylornithine, an ornithine decarboxylase inhibitor. Cancer Res. 41: 4426-4431, 1981.
30. Wilson, C. B., Gutin, P. H., Boldrey, E. B., Crafts, D. Levin, V. A., and Enot, K. J., Single-agent chemotherapy of brain tumors. A five-year review. Arch. Neurol. 33: 739-744, 1976.
31. Tomaydo, M. M., and Reynolds, C. P., Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24: 148-154, 1989.
32. Mitchell, R. B., Moschel, R. C., and Dolan, M. E., Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to l, 3-bis(2-chloroethyl)-l-nitrosourea and on DNA intrastrand cross-link formation. Cancer Res. 52: 1171-1175, 1992.
33. Casero, R. A., Jr. Celano, P. Ervin, S. J., Porter, C. W., Bergeron, R. J., and Libby, P. R., Differential induction of spermidine/spermine N1-acetyltransferase in human lung cancer cells by the bis(ethyl)polyamine analogues. Cancer Res. 49: 3829-3833, 1989.
34. Ghoda, L. Basu, H. S., Porter, C. W., Marton, L. J., and Coffino, P. Role of ornithine decarboxylase suppression and polyamine depletion in the antiproliferative activity of polyamine analogs. Mol. Pharmacol. 42: 302-306, 1992.
35. Albanese, L. Bergeron, R. J., and Pegg, A. E., Investigations of the mechanism by which mammalian cell growth is inhibited by N1, N12-bisfcthyl)spermine. Biochem. J. 291: 131-137, 1993.